Combinatorial therapies for spinal cord injury: strategies to induce regeneration by Gomes, Eduardo Domingos Correia et al.
www.nrronline.org
1
NEURAL REGENERATION RESEARCH 
PERSPECTIVE
Combinatorial therapies for spinal 
cord injury: strategies to induce 
regeneration
Spinal cord injury (SCI) is a condition without treatment, 
mainly characterized by the loss of motor and sensory 
function below the level of injury. This is accompanied 
by several complications such as cardiac and respiratory 
compromise, and often patients present psychological ail-
ments associated with the drastic alteration of their nor-
mal lifestyle. SCI pathophysiology derives from a massive 
damage to the spinal cord tissue, which is propagated by 
secondary events such as inflammation, excitotoxicity 
among others, that increase neuronal loss. In a later stage, 
a glial scar composed by reactive astrocytes and a cystic 
cavity are formed, creating a physical and chemical bar-
rier for axonal regrowth. Strategies capable of inducing 
neuronal regeneration are therefore a fundamental part 
for a successful recovery of function for these patients.
In the last two decades, the tissue engineering (TE) field 
has shown promising advances, mainly at the pre-clinical 
level, aiming at SCI repair. Based on TE principles, the 
first studies were focused on developing a matrix (or scaf-
fold) with physical properties similar to the spinal cord 
tissue. At the same time, these matrices are required to 
be biocompatible and biodegradable, while avoiding any 
enhanced inflammatory response. One of the first studies, 
mentioning the application of a matrix after a SCI, was 
done by de la Torre and colleagues, in 1984 (de la Torre 
et al., 1984). Using a collagen matrix (CM) implanted 
in situ at a T10 complete transection injury in rats, the 
authors report that the CM supported the growth of cen-
tral neurites, fibroblasts and a network of blood vessels, 
which did not happen in control animals. Even though 
no improvements were seen in motor behavior, early 
waveforms of somatosensory evoked potentials were ob-
served in CM-treated rats (de la Torre et al., 1984).
The concept of creating a bridge over the lesion is even 
older, with peripheral nerve grafts being performed after 
an injury, resulting in impressing levels of regeneration 
(David and Aguayo, 1981). However, unlike peripheral 
nerve, CNS tissue has a very limited capacity of self-re-
generation, which has been hindering the development 
of successful therapies. Growth factors for instance, have 
been commonly associated with scaffolds to increase 
axonal regrowth. An elegant work from Anderson et al. 
(2016) demonstrated that a synthetic diblock co-poly-
peptide hydrogel, composed of lysin and leucine resi-
dues, served as a depot for neurotrophin-3 (NT3) and 
brain-derived neurotrophic factor (BDNF) delivery. This 
approach, when conjugated to a peripheral conditioning 
lesion, led to robust ascending sensory tract axons re-
growth into the lesion core, after a compression injury at 
T10 level, in a mice SCI model. Interestingly, the axons 
even grew through and beyond dense astrocytic scars 
(Anderson et al., 2016).
Cellular therapies have also been on the forefront of 
TE regeneration strategies. Either with the objective of 
replacing the neural tissue, or simply providing trophic 
support to increment endogenous regeneration, trans-
planted cells may play a key role in SCI treatment. How-
ever, cell survival in transplants to the injured spinal cord 
is very low, a fact that partially hinders their success as a 
therapeutic strategy. In this sense, the conjugation of cel-
lular therapies with biomaterials is of great interest, since 
these scaffolds could serve not only as bridges for axonal 
regeneration, but also as vehicles for cellular transplanta-
tion.
In vitro testing of different biomaterials’ suitability to 
induce cellular growth and neurite extension is therefore 
crucial. Our group directly compared three different ex-
tracellular matrix (ECM)-derived hydrogels in their ca-
pability to serve as a matrix for adipose stem cells (ASCs) 
growth and neurite formation and extension, using dorsal 
root ganglia (DRG) explants (Oliveira et al., 2017). One 
hydrogel was made of gellan gum (GG), a polysaccharide 
produced by bacteria; other was made of collagen and 
another one made of hyaluronic acid and rich in lami-
nin epitopes. Interestingly, ASCs grew differently in all 
the three matrices, presenting altered levels of metabolic 
activity and gene expression, and even DRG neurite out-
growth mediated by ASCs was different according to each 
type of hydrogel (Oliveira et al., 2017). In this particu-
lar study, even though all three hydrogels were derived 
from natural polymers, the different source might have 
been a key aspect for the results obtained. Moreover, the 
physical properties of each hydrogel were most certainly 
very important. Differences in porosity and stiffness are 
known to affect the behavior of cells, particularly stem 
cells (Engler et al., 2006). For instance, Engler et al. (2006) 
demonstrated that matrices that mimic striated muscle 
elasticity (8–17 kPa) induce mesenchymal stem cells 
(MSCs) differentiation to myoblast-like cells, while stiffer 
matrices mimicking collagenous bone (25–40 kPa) can be 
osteogenic. Curiously, it was demonstrated that although 
reprogramming MSCs differentiation is possible with sol-
uble factors, after several weeks in culture, cells eventually 
commit to the lineage specified by matrix elasticity, high-
lighting the importance of the matrix physical properties 
in cellular behavior.
In addition to physical characteristics, the presence of 
chemical cues is fundamental for cellular growth within 
any type of scaffold. In this matter, our group has done an 
extensive characterization on the role of RGD motifs and 
their integration into GG-based hydrogels, evaluating 
the adhesion of different cell types, growth and paracrine 
secretion. By using Diels-Alder click chemistry to modify 
GG with a fibronectin-derived peptide (GRGDS), we im-
proved the morphology and proliferation of neural stem/
progenitor cells (NSPCs) (Silva et al., 2012), a cell popu-
lation commonly used in SCI-based pre-clinical studies. 
The same GG-GRGDS hydrogel formulation induced 
higher proliferation and metabolic activity of bone mar-
row MSCs (BM-MSCs), with cells presenting a normal 
morphology only in modified GG hydrogels (Silva et al., 
2013). This chemical alteration also led to changes in the 
molecules secreted by BM-MSCs (the secretome), since 
they induced higher metabolic viabilities and neuronal 
cell densities, when compared to the secretome of cells 
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Figure 1 Combinatorial therapies for spinal cord injury (SCI) regeneration. 
The use of brain-machine interfaces (BMIs), Epidural Stimulation and Neurorehabilitation strategies could be combined in the future with Tissue 
Engineering approaches (biomaterials, cell therapy and drug administration) to maximize the therapeutic effect and induce neuronal regeneration.
cultured in unmodified GG. 
Nevertheless, although in vitro testing is important as a 
first assessment measure, in vivo experiments are crucial, 
because it is still not possible to fully recreate the lesion 
microenvironment. Taking this into account, our group 
showed a promising role for GG-GRGDS hydrogels 
in vivo (Gomes et al., 2016). When transplanted into a 
lumbar hemisection model of SCI, GG-GRGDS com-
bined with ASCs and olfactory ensheathing cells (OECs) 
induced a significant recovery of motor scores of SCI 
rats, together with reduced levels of astrocytes and in-
flammatory cells, at the site of injury. Importantly, higher 
number of neurofilament positive cells indicate a possible 
increase in neuronal preservation after injury and/or in-
creased regeneration (Gomes et al., 2016). Even though 
these results are encouraging, especially considering the 
aggressive injury induced (lumbar lesion model), there 
was still a restricted number of neurons/axons invading 
the lesion core, and the recovery of motor function was 
only partial.
Although these results are positive, there is a lack of 
studies combining a strategy that tackles both the second-
ary events responsible for neuronal death and inhibition 
of axonal growth, enabling at the same time, the tissue to 
regenerate. On one side, the ideal therapeutic approach 
would conjugate a biomaterial that could serve both as a 
vehicle for different treatment options (cells, drugs, neu-
rotrophic factors) and simultaneously could be a suitable 
matrix, allowing the tissue to regenerate through it. This 
kind of scaffold should not induce any type of additional 
inflammatory response, hence the frequent use of natural 
and ECM-derived materials. Then, it should degrade with 
time, not too quickly so the cells or drugs would be rapid-
ly lost and not integrated into the host tissue, but not too 
slowly, so it can be gradually replaced by newly formed 
neuronal tissue. On the other hand, this kind of strategy 
should be complemented with treatments focused on 
the abovementioned secondary events: drugs that could 
1) target inflammation, so that it remains as a normal 
response to injury and does not develop into a chronic 
inflammatory state; 2) deal with the neurotoxicity derived 
from the excessive release of glutamate; 3) find ways to 
diminish the inhibitory signals of axonal regrowth, for 
instance degrading the glial scar.
The source of cells to be used in TE applications is an-
other critical issue. The cells should derive from a source 
as much available as possible, and autologous sources are 
preferable, so immune rejection can be avoided.
Another great challenge in this field is the regenera-
tion specificity of the damaged spinal cord. Usually, the 
regrowth of damaged axons is made in a disorganized 
fashion, losing completely the distinct organization of the 
spinal cord axonal tracts. In order to minimize this effect, 
Stokols and Tuszynski developed freeze-dried agarose 
scaffolds, with uniaxial individual channels extending 
through the entire length of the scaffold (Stokols and 
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Tuszynski, 2006). One month after an injury in rats, the 
scaffolds integrated the host tissue, being penetrated by 
different cells and amazingly axons grew in a linear fash-
ion. The incorporation of BDNF into the walls and lumen 
of the scaffold augmented axonal regeneration.
Some of the most promising works for the future of 
SCI field include epidural stimulation and the use of 
brain-machine interfaces (BMIs). These strategies repre-
sent big hopes for SCI patients and have different prin-
ciples underlying their application. Gregoire Courtine’s 
group for instance, has been working on different models 
of electrochemical neuromodulation, being capable of 
inducing circuit reorganization after a SCI in rats (Asboth 
et al., 2018). On the other hand, Miguel Nicolelis’ group 
has paved the way of BMI applications, that could be used 
for the creation of neuroprostheses and applied to a SCI 
context (Lebedev and Nicolelis, 2017). The use of both 
kinds of approach is exciting because they are associated 
to neuronal plasticity events. Nevertheless, inherent dif-
ferences between species have to be taken into account, 
since the functional state of the spinal cord pre- and 
post-lesion varies from lower vertebrates, to small mam-
mals or humans. In the same line of thought, the response 
to drug therapy might differ among species, making diffi-
cult to predict the success of a given treatment. Therefore, 
there is a need for combined therapies that could pro-
mote and guide the often disorganized neuronal plasticty, 
in order to induce some recovery of function, which is of 
the utmost importance for patients. Treadmill training 
and other rehabilitation regimens have been commonly 
associated with epidural stimulation (Angeli et al., 2014). 
This kind of repetitive and active training could be essen-
tial for stimulating neuronal circuitry reorganization and 
for the initiation of voluntary movements. In this sense, 
in the future, BMIs, epidural stimulation and neuroreha-
bilitation should be combined with TE guidance strate-
gies, increasing the chances of recovery after SCI (Figure 
1). By using an integrated and combinatorial therapeutic 
approach, based on biology, as well as tissue and com-
puter engineering concepts, we may achieve a successful 
therapy for SCI.
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